4th Quarter - Report

MEHLMAN CONSULTING, INC. for MAYO CLINIC

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Quality payments for providers. Accountable care organizations. Clinical laboratory reimbursement. Physician payment policies. Chronic healthcare. Overlapping; concurrent surgery oversight.

Contacted: HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); Office of Science & Technology Policy (OSTP); SENATE; Health & Human Services, Dept of (HHS)

Health Issues HCR

General healthcare. Health reform implementation. Healthcare value and quality. Health information technology, clinical trials, telehealth. Precision medicine, delivery system reform. S. 2713, Advancing Precision Medicine Act of 2016. H.R. 6, 21st Century Cures Act. Moonshot Cancer Initiative. S. 2742, Promoting Biomedical Research and Public Health for Patients Act. S. 2745, Advancing NIH Strategic Planning and Representation in Medical Research Act.

Contacted: SENATE; Office of Science & Technology Policy (OSTP); Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Bills named: S. 2745 (114th), S. 2742 (114th), S. 2713 (114th), H.R. 6 (114th)

Medical/Disease Research/Clinical Labs MED

FY17 Labor-Health and Human Services-Education Appropriations bill (NIH funding). Clinical laboratory reimbursement.

Contacted: HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); SENATE; Office of Science & Technology Policy (OSTP)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.